Liquidia Q3 2026 net loss widens year over year to $236.3 million

Bitget2026/11/10 11:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Liquidia’s third-quarter 2026 net loss widened year over year to $236.3 million, including a $389.7 million litigation settlement charge.
YUTREPIA net product sales rose to $222.7 million, up 31% from the second quarter of 2026.
Cash and cash equivalents more than doubled from December 31, 2025, to $396.1 million at September 30, 2026, before settlement payments.
A global settlement with United Therapeutics requires $380.7 million in net payments during 2026–2027 while preserving uninterrupted patient access to YUTREPIA.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liquidia Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611100630PRIMZONEFULLFEED9874084) on November 10, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Liquidia Q3 2026 net loss widens year over year to $236.3 million

You may also like

Crypto prices